Advertisement

Topics

FORMA Therapeutics Appoints Christine Bellon, Ph.D., J.D., General Counsel and Corporate Secretary

08:00 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
FORMA Therapeutics announced today that Christine (Chris) P. Bellon, Ph.D., J.D., has been appointed to the position of Senior Vice President, General Counsel and Corporate Secretary. Chris joins the executive leadership team of...

Other Sources for this Article

For FORMA Therapeutics
MacDougall Biomedical Communications
Kari Watson or Kara Mazey, +1 781-235-3060
kwatson@macbiocom.com or kmazey@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "FORMA Therapeutics Appoints Christine Bellon, Ph.D., J.D., General Counsel and Corporate Secretary"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...